Safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of a dual GLP-1/GIP receptor agonist (HRS9531) in T2DM patients: a randomized, double-blind, placebo- and open-label positive-controlled phase 1b trial
N-Acetyl-L-Cysteine (NAC) is frequently paired with glutathione, as NAC provides the rate-limiting amino acid (cysteine) required for the body to synthesize its own endogenous glutathione, creating a powerful two-pronged approach to antioxidant support
AMPK regulates autophagy and ferroptosis, as well as acting as a negative modulator of mtROS (34, 79, 198)
Want access to multiple medication options: If you and your clinician want the flexibility to choose from branded GLP-1 injectables, oral options, non-GLP-1 medications, and compounded alternatives under one clinical umbrella, Found Health describes a wide range of medication options within its program
2019;31:e1805955
A provider can evaluate your health history, metabolic profile, and weight-loss goals to determine whether this therapy aligns with your long-term plan for improved health and sustainability